UTI (Urinary Tract Infection) Treatment Market to reach US$ 9 Mn by 2029 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

UTI (Urinary Tract Infection) Treatment Market to reach US$ 9 Mn by 2029

Description:

The increasing prevalence of urinary tract infection (UTI) and growth in the number of prescription of quinolones antibiotics is expected to fuel the growth of the urinary tract infection treatment market. According to a new study published by Future Market Insights (FMI), the global urinary tract infection treatment market revenues will grow at a mere 2% CAGR between 2019 and 2029. – PowerPoint PPT presentation

Number of Views:23

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: UTI (Urinary Tract Infection) Treatment Market to reach US$ 9 Mn by 2029


1
UTI (Urinary Tract Infection) Treatment Market
  • October 2016

Report Id REP-AS-661 Published On
July-2015 Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

SOLUTION
  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
4
UTI (Urinary Tract Infection) Treatment Market
Analysis
  • The increasing prevalence of urinary tract
    infection (UTI) and growth in the number of
    prescription of quinolones antibiotics is
    expected to fuel the growth of the urinary tract
    infection treatment market. According to a new
    study published by Future Market Insights (FMI),
    the global urinary tract infection treatment
    market revenues will grow at a mere 2 CAGR
    between 2019 and 2029.
  • Launch of New Antibiotics for Bacterial
    Infections to Sustain Revenues
  • Increase in the number of research and
    development initiatives for the developing novel
    therapeutics has led to the launch of new drugs
    into the urinary tract infection treatment
    market. Manufacturers are currently focusing on
    expanding their pipeline portfolio for the
    treatment of bacterial infections. Moreover,
    regulatory bodies such as FDA have accelerated
    the approval process of drugs.

5
UTI (Urinary Tract Infection) Treatment Market
Analysis
  • Recently, in August 2018, Melinta Therapeutics
    announced the launch of Vabomere (meropenem and
    vaborbactam) for patients who require treatment
    for complicated urinary tract infection.
    Similarly, one more drug has been approved by FDA
    in June 2018, Zemdri by Achaogen, Inc., for the
    treatment of adults suffering from Complicated
    Urinary Tract Infection (cUTI). Increase in the
    launch and approval of novel therapeutics for the
    treatment of bacterial infections is expected to
    contribute to the growth of the urinary tract
    infection treatment market.
  • Quinolones, the broad spectrum antibiotics
    effective against a wide range of bacterial
    disease, have bactericidal activity that enables
    them to penetrate deep into the tissue. Their
    excellent bioavailability is a plus point. In
    addition, they have favourable tolerability and
    safety profile. Moreover, they have significant
    antimicrobial activity. Thus, quinolones are most
    preferred for the treatment of urinary tract
    infection. Some of the widely used quinolones for
    the prevention of bacterial infection include
    ciprofloxacin (Cipro), ofloxacin (Floxin),
    norfloxacin (Noroxin), and others. Quinolones are
    mostly favored over trimethoprim-sulfamethoxazole
    (TMP-SMX) for the treatment of uncomplicated
    urinary tract infections owing to the increasing
    resistance of bacteria towards antibiotics such
    as trimethoprim-sulfamethoxazole, beta lactam
    antibiotics, and others.

6
UTI (Urinary Tract Infection) Treatment Market
Analysis
  • Europe Remains Major Revenue Contributor
  • Europe holds a considerable revenue share in the
    UTI treatment market. The rising prevalence of
    urinary tract infection among the population and
    increasing hospital visits are among factors that
    are likely to propel the growth of the urinary
    tract infection treatment market. It is estimated
    that the urinary tract infection treatment market
    will create an incremental opportunity worth
    nearly US 9 Mn between 2019 and 2029. Quinolones
    is anticipated to boost the growth of the urinary
    tract infection treatment market owing to the
    increasing prescription and high effectivity as
    antimicrobial antibiotics.

7
UTI (Urinary Tract Infection) Treatment Market
Analysis
Demand from Retail Pharmacies to Register High
Growth The global urinary tract infection
treatment market has been segmented on the basis
of drug class, indication, and distribution
channel. On the basis of drug class, the urinary
tract infection treatment market has been
segmented into Penicillin Combinations,
Quinolones, Cephalosporin, Aminoglycoside
Antibiotics, Sulphonamides (Sulfamethoxazole
Trimethoprim), Azoles and Amphotericin B,
Tetracycline (Doxycycline), Nitrofurans
(Nitrofurantoin), and others. In terms of
revenue, the quinolones segment is expected to
hold a major share of the urinary tract infection
treatment market during the forecast period since
it is widely prescribed and has proven to be safe
and effective for antimicrobial use. Based on
indication, the urinary tract infection treatment
market has been segmented into complicated
urinary tract infection and uncomplicated urinary
tract infection. On the basis of distribution
channel, the urinary tract infection treatment
market has been categorised into hospital
pharmacies, gynaecology urology clinics, drug
stores, retail pharmacies, and online drug
stores. The retail pharmacies segment is expected
to exhibit high revenue growth in the urinary
tract infection treatment market owing to the
easy availability of antibiotics.
8
UTI (Urinary Tract Infection) Treatment Market
Analysis
  • Key Companies in Urinary Tract Infection
    Treatment Market
  • The report studies some of the key companies
    operating in the urinary tract infection
    treatment market, such as Bayer AG,
    GlaxoSmithKline Pharmaceuticals Ltd., Pfizer,
    Allergan Plc, Almirall SA, Bristol-Myers Squibb,
    and Merck Co., Inc. For more insights on the
    competitive landscape and other facets shaping
    the growth of UTI treatment market.
  • Press Release Source https//www.prnewswire.com/n
    ews-releases/urinary-tract-infection-treatment-mar
    ket-in-a-slump-revenues-poised-for-2-cagr-over-201
    9-2029--future-market-insights-300876019.html
  • More from FMIs Healthcare, Pharmaceuticals and
    Medical devices Market Intelligence
  • Memory Enhancing Drugs Market
  • Home Sleep Screening Devices Market
  • Fluorescence Spectroscopy Market

9
UTI (Urinary Tract Infection) Treatment Market
Analysis
    About Future Market Insights (FMI) Future
Market Insights (FMI) is a leading provider of
market intelligence and consulting services,
serving clients in over 150 countries. FMI is
headquartered in London, the global financial
capital, and has delivery centers in the U.S. and
India. FMIs largest market research reports and
industry analysis help businesses navigate
challenges and take critical decisions with
confidence and clarity amidst breakneck
competition. Request for covid19 Impact
Analysis https//www.futuremarketinsights.com/cov
id19/rep-gb-1340
10
UTI (Urinary Tract Infection) Treatment Market
Analysis
Contact Mr. Abhishek Budholiya Unit No AU-01-H
Gold Tower (AU), Plot No JLT-PH1-I3A, Jumeirah
Lakes Towers, Dubai, United Arab Emirates MARKET
ACCESS DMCC Initiative For Sales
Enquiries sales_at_futuremarketinsights.com For
Media Enquiries press_at_futuremarketinsights.com Fu
ture Market Insights
For more insights on the UTI (Urinary Tract
Infection) Treatment Market,you can request a
report sample with full TOC at http//www.futurema
rketinsights.com/reports/sample/rep-as-661
11
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
About PowerShow.com